Does treatment with somatostatin analogs differ in the uptake of normal target organs and malignant lesions on 68Ga-DOTATATE PET/CT imaging?

Does treatment with somatostatin analogs differ in the uptake of normal target organs and malignant lesions on 68Ga-DOTATATE PET/CT imaging?

Abstract Objective: Somatostatin analogs (SSA) are used in treating low-grade neuroendocrine tumors, mainly because of their antiproliferative effect. 68Ga tetraazacyclododecantetraacetic acid-DPhe1-Tyr3-octreotate (DOTATATE) PET/CT as somatostatin receptor imaging has been widely used in recent ye...

Full description

Bibliographic Details
Main Authors: Çağlagül Erol, Ahmet Volkan Çelik, Özlem Şahin, Gonca Kara Gedik, Hasan Önner, Farise Yılmaz
Format: Article
Language:English
Published: Selcuk University Press 2022-08-01
Series:Genel Tıp Dergisi
Subjects:
68ga-dotatate pet/ct
somatostatin analogs
neuroendocrine tumors.
nöroendokrin tümörler
68ga-dotatate pet/bt
somatostatin analogları
Online Access:https://dergipark.org.tr/tr/download/article-file/2581308

Internet

https://dergipark.org.tr/tr/download/article-file/2581308

Similar Items